ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2026
Outpatient care for venous leg ulceration in Germany: A retrospective claims data analysis.
Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Implementing a primary care disease management concept for venous leg ulceration: findings of a mixed-methods process evaluation in the Ulcus Cruris Care trial.BMC health services research · 2026Trial
- Underprovision of Medical Compression Therapy: Retrospective Analysis Based on Statutory Health Insurance Data on Venous Leg Ulcers, Chronic Venous Disease and Comorbidities.International wound journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
objectivesOutpatient care of venous leg ulcers (VLU) is a problem of high medical and health economic relevance. Treatment is often inconsistent and not guideline-compliant. The project Ulcus Cruris Care investigated the VLU outpatient care situation in Germany. PATIENTS AND
methodsReimbursement data of 40,046 patient cases (2015-2019) with VLU diagnosis from a statutory health insurer (AOK Baden-Wuerttemberg, Germany) were retrospectively analyzed. Outcome assessment was based on prescriptions, medical aids, nursing care, use of compression devices, surgical procedures and treatment costs.
results47.3% (n = 7,581) of patients without contraindication received a compression device within 90 days. 2.3% (n = 135) received surgical truncal vein interventions. 14.1% (n = 771) received consistent compression therapy associated with faster wound healing (121.6 ± 86.2 vs. 188.1 ± 164.2 days, p < 0.001), lower total costs (4,280 ± 5,326 € vs. 5,683 ± 9,657 €, p < 0.001) and lower disease-specific costs (2,498 ± 2,785 € vs. 2,797 ± 5,145 €, p = 0.017) versus no or unsteady treatment.
conclusionsIn outpatient VLU care around 80% of patients do not receive consistent compression therapy and are therefore not adequately treated. There is an urgent need for action to improve treatment of patients with VLU in Germany.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.